Guidelines for Neuroprognostication in Critically Ill Adults with Moderate-Severe Traumatic Brain Injury.
Neurocritical care
Outcome
Prognosis
Prognostication
Traumatic brain injury
Journal
Neurocritical care
ISSN: 1556-0961
Titre abrégé: Neurocrit Care
Pays: United States
ID NLM: 101156086
Informations de publication
Date de publication:
17 Feb 2024
17 Feb 2024
Historique:
received:
17
11
2023
accepted:
22
11
2023
medline:
17
2
2024
pubmed:
17
2
2024
entrez:
17
2
2024
Statut:
aheadofprint
Résumé
Moderate-severe traumatic brain injury (msTBI) carries high morbidity and mortality worldwide. Accurate neuroprognostication is essential in guiding clinical decisions, including patient triage and transition to comfort measures. Here we provide recommendations regarding the reliability of major clinical predictors and prediction models commonly used in msTBI neuroprognostication, guiding clinicians in counseling surrogate decision-makers. Using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology, we conducted a systematic narrative review of the most clinically relevant predictors and prediction models cited in the literature. The review involved framing specific population/intervention/comparator/outcome/timing/setting (PICOTS) questions and employing stringent full-text screening criteria to examine the literature, focusing on four GRADE criteria: quality of evidence, desirability of outcomes, values and preferences, and resource use. Moreover, good practice recommendations addressing the key principles of neuroprognostication were drafted. After screening 8125 articles, 41 met our eligibility criteria. Ten clinical variables and nine grading scales were selected. Many articles varied in defining "poor" functional outcomes. For consistency, we treated "poor" as "unfavorable". Although many clinical variables are associated with poor outcome in msTBI, only the presence of bilateral pupillary nonreactivity on admission, conditional on accurate assessment without confounding from medications or injuries, was deemed moderately reliable for counseling surrogates regarding 6-month functional outcomes or in-hospital mortality. In terms of prediction models, the Corticosteroid Randomization After Significant Head Injury (CRASH)-basic, CRASH-CT (CRASH-basic extended by computed tomography features), International Mission for Prognosis and Analysis of Clinical Trials in TBI (IMPACT)-core, IMPACT-extended, and IMPACT-lab models were recommended as moderately reliable in predicting 14-day to 6-month mortality and functional outcomes at 6 months and beyond. When using "moderately reliable" predictors or prediction models, the clinician must acknowledge "substantial" uncertainty in the prognosis. These guidelines provide recommendations to clinicians on the formal reliability of individual predictors and prediction models of poor outcome when counseling surrogates of patients with msTBI and suggest broad principles of neuroprognostication.
Sections du résumé
BACKGROUND
BACKGROUND
Moderate-severe traumatic brain injury (msTBI) carries high morbidity and mortality worldwide. Accurate neuroprognostication is essential in guiding clinical decisions, including patient triage and transition to comfort measures. Here we provide recommendations regarding the reliability of major clinical predictors and prediction models commonly used in msTBI neuroprognostication, guiding clinicians in counseling surrogate decision-makers.
METHODS
METHODS
Using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology, we conducted a systematic narrative review of the most clinically relevant predictors and prediction models cited in the literature. The review involved framing specific population/intervention/comparator/outcome/timing/setting (PICOTS) questions and employing stringent full-text screening criteria to examine the literature, focusing on four GRADE criteria: quality of evidence, desirability of outcomes, values and preferences, and resource use. Moreover, good practice recommendations addressing the key principles of neuroprognostication were drafted.
RESULTS
RESULTS
After screening 8125 articles, 41 met our eligibility criteria. Ten clinical variables and nine grading scales were selected. Many articles varied in defining "poor" functional outcomes. For consistency, we treated "poor" as "unfavorable". Although many clinical variables are associated with poor outcome in msTBI, only the presence of bilateral pupillary nonreactivity on admission, conditional on accurate assessment without confounding from medications or injuries, was deemed moderately reliable for counseling surrogates regarding 6-month functional outcomes or in-hospital mortality. In terms of prediction models, the Corticosteroid Randomization After Significant Head Injury (CRASH)-basic, CRASH-CT (CRASH-basic extended by computed tomography features), International Mission for Prognosis and Analysis of Clinical Trials in TBI (IMPACT)-core, IMPACT-extended, and IMPACT-lab models were recommended as moderately reliable in predicting 14-day to 6-month mortality and functional outcomes at 6 months and beyond. When using "moderately reliable" predictors or prediction models, the clinician must acknowledge "substantial" uncertainty in the prognosis.
CONCLUSIONS
CONCLUSIONS
These guidelines provide recommendations to clinicians on the formal reliability of individual predictors and prediction models of poor outcome when counseling surrogates of patients with msTBI and suggest broad principles of neuroprognostication.
Identifiants
pubmed: 38366277
doi: 10.1007/s12028-023-01902-2
pii: 10.1007/s12028-023-01902-2
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Centers for Disease Control and Prevention (2022) Get the Facts: TBI Data. 2021 (Accessed 9/30/2021) at https;// www.cdc.gov/traumaticbraininjury/data/index/html . https;// www.cdc.gov/traumaticbraininjury/data/index/html .
Iaccarino C, Carretta A, Nicolosi F, Morselli C. Epidemiology of severe traumatic brain injury. J Neurosurg Sci. 2018;62(5):535–41.
pubmed: 30182649
doi: 10.23736/S0390-5616.18.04532-0
Centers for Disease Control and Prevention (2022) Moderate to Severe TBI is a life-long condition. 2021. Accessed 30 June 2021. https://www.cdc.gov/traumaticbraininjury/pdf/Moderate_to_Severe_TBI_Lifelong-a.pdf .
Centers for Disease Control and Prevention (2022) TBI report to Congress. 2016. (Accessed 9/30/2021). https://www.cdc.gov/traumaticbraininjury/pubs/tbi_report_to_congress.html#:~:text=For%20the%20estimated%205 3%20million,full%20human%20cost%20is%20incalculable.
Turgeon AF, Lauzier F, Simard JF, et al. Mortality associated with withdrawal of life-sustaining therapy for patients with severe traumatic brain injury: a Canadian multicentre cohort study. CMAJ. 2011;183(14):1581–8.
pubmed: 21876014
pmcid: 3185074
doi: 10.1503/cmaj.101786
Muehlschlegel S, Carandang R, Ouillette C, Hall W, Anderson F, Goldberg R. Frequency and impact of intensive care unit complications on moderate-severe traumatic brain injury: early results of the Outcome Prognostication in Traumatic Brain Injury (OPTIMISM) Study. Neurocrit Care. 2013;18(3):318–31.
pubmed: 23377884
doi: 10.1007/s12028-013-9817-2
van Veen E, van der Jagt M, Citerio G, et al. Occurrence and timing of withdrawal of life-sustaining measures in traumatic brain injury patients: a CENTER-TBI study. Intensive Care Med. 2021;47(10):1115–29.
pubmed: 34351445
pmcid: 8486724
doi: 10.1007/s00134-021-06484-1
Quinn T, Moskowitz J, Khan MW, et al. What families need and physicians deliver: contrasting communication preferences between surrogate decision-makers and physicians during outcome prognostication in critically ill TBI patients. Neurocrit Care. 2017;27(2):154–62.
pubmed: 28685395
pmcid: 5693603
doi: 10.1007/s12028-017-0427-2
Creutzfeldt CJ, Longstreth WT, Holloway RG. Predicting decline and survival in severe acute brain injury: the fourth trajectory. BMJ. 2015;351: h3904.
pubmed: 26251409
doi: 10.1136/bmj.h3904
Schutz RE, Coats HL, Engelberg RA, Curtis JR, Creutzfeldt CJ. Is there hope? Is she there? How families and clinicians experience severe acute brain injury. J Palliat Med. 2017;20(2):170–6.
pubmed: 27763820
doi: 10.1089/jpm.2016.0286
Izzy S, Compton R, Carandang R, Hall W, Muehlschlegel S. Self-fulfilling prophecies through withdrawal of care: Do they exist in traumatic brain injury, too? Neurocrit Care. 2013;19(3):347–63.
pubmed: 24132565
doi: 10.1007/s12028-013-9925-z
Hemphill JC, White DB. Clinical nihilism in neuroemergencies. Emerg Med Clin North Am. 2009;27(1):27–viii.
pmcid: 2676162
doi: 10.1016/j.emc.2008.08.009
Williamson T, Ryser MD, Ubel PA, et al. Withdrawal of life-supporting treatment in severe traumatic brain injury. JAMA Surg. 2020;155(8):723–31.
pubmed: 32584926
pmcid: 7301301
doi: 10.1001/jamasurg.2020.1790
Watanitanon A, Lyons VH, Lele AV, et al. Clinical epidemiology of adults with moderate traumatic brain injury. Crit Care Med. 2018;46(5):781–7.
pubmed: 29369057
pmcid: 5899009
doi: 10.1097/CCM.0000000000002991
Gritti P, Zangari R, Carobbio A, et al. Acute and subacute outcome predictors in moderate and severe traumatic brain injury: a retrospective monocentric study. World Neurosurg. 2019;128:e531–40.
pubmed: 31048051
doi: 10.1016/j.wneu.2019.04.190
Hukkelhoven CW, Steyerberg EW, Rampen AJ, et al. Patient age and outcome following severe traumatic brain injury: an analysis of 5600 patients. J Neurosurg. 2003;99(4):666–73.
pubmed: 14567601
doi: 10.3171/jns.2003.99.4.0666
Latronico N, Piva S, Fagoni N, et al. Impact of a posttraumatic cerebral infarction on outcome in patients with TBI: the Italian multicenter cohort INCEPT study. Crit Care. 2020;24(1):33–2746.
pubmed: 32014041
pmcid: 6998281
doi: 10.1186/s13054-020-2746-5
Ziaeirad M, Alimohammadi N, Irajpour A, Aminmansour B. Association between outcome of severe traumatic brain injury and demographic, clinical, injury-related variables of patients. Iran J Nurs Midwifery Res. 2018;23(3):211–6.
pubmed: 29861760
pmcid: 5954643
doi: 10.4103/ijnmr.IJNMR_65_17
Majdan M, Mauritz W, Wilbacher I, Brazinova A, Rusnak M, Leitgeb J. Timing and duration of intracranial hypertension versus outcomes after severe traumatic brain injury. Minerva Anestesiol. 2014;80(12):1261–72.
pubmed: 24622160
Gao G, Wu X, Feng J, et al. Clinical characteristics and outcomes in patients with traumatic brain injury in China: a prospective, multicentre, longitudinal, observational study. Lancet Neurol. 2020;19(8):670–7.
pubmed: 32702336
doi: 10.1016/S1474-4422(20)30182-4
Brennan PM, Murray GD, Teasdale GM. Simplifying the use of prognostic information in traumatic brain injury. Part 1: the GCS-Pupils score: an extended index of clinical severity. J Neurosurg. 2018;128(6):1612–20.
pubmed: 29631516
doi: 10.3171/2017.12.JNS172780
Chang HYM, Flahive J, Bose A, et al. Predicting mortality in moderate-severe TBI patients without early withdrawal of life-sustaining treatments including ICU complications: the MYSTIC-score. J Crit Care. 2022;72: 154147.
pubmed: 36166912
doi: 10.1016/j.jcrc.2022.154147
Steyerberg EW, Mushkudiani N, Perel P, et al. Predicting outcome after traumatic brain injury: development and international validation of prognostic scores based on admission characteristics. PLoS Med. 2008;5(8): e165.
pubmed: 18684008
pmcid: 2494563
doi: 10.1371/journal.pmed.0050165
Manley G, Knudson MM, Morabito D, Damron S, Erickson V, Pitts L. Hypotension, hypoxia, and head injury: frequency, duration, and consequences. Arch Surg. 2001;136(10):1118–23.
pubmed: 11585502
doi: 10.1001/archsurg.136.10.1118
Merck LH, Yeatts SD, Silbergleit R, et al. The effect of goal-directed therapy on patient morbidity and mortality after traumatic brain injury: results from the progesterone for the treatment of traumatic brain injury III clinical trial. Crit Care Med. 2019;47(5):623–31.
pubmed: 30730438
pmcid: 7778459
doi: 10.1097/CCM.0000000000003680
Spaite DW, Hu C, Bobrow BJ, et al. Association of out-of-hospital hypotension depth and duration with traumatic brain injury mortality. Ann Emerg Med. 2017;70(4):522–30.
pubmed: 28559036
pmcid: 5614805
doi: 10.1016/j.annemergmed.2017.03.027
Briain D, Nickson C, Pilcher DV, Udy AA. Early hyperoxia in patients with traumatic brain injury admitted to intensive care in Australia and New Zealand: a retrospective multicenter cohort study. Neurocrit Care. 2018;29(3):443–51.
doi: 10.1007/s12028-018-0553-5
Davis DP, Meade W, Sise MJ, et al. Both hypoxemia and extreme hyperoxemia may be detrimental in patients with severe traumatic brain injury. J Neurotrauma. 2009;26(12):2217–23.
pubmed: 19811093
doi: 10.1089/neu.2009.0940
Lazaridis C, DeSantis SM, Smielewski P, et al. Patient-specific thresholds of intracranial pressure in severe traumatic brain injury. J Neurosurg. 2014;120(4):893–900.
pubmed: 24506248
doi: 10.3171/2014.1.JNS131292
van Leeuwen N, Lingsma HF, Perel P, et al. Prognostic value of major extracranial injury in traumatic brain injury: an individual patient data meta-analysis in 39,274 patients. Neurosurgery. 2012;70(4):811–8.
pubmed: 21904253
doi: 10.1227/NEU.0b013e318235d640
Watanabe T, Kawai Y, Iwamura A, Maegawa N, Fukushima H, Okuchi K. Outcomes after traumatic brain injury with concomitant severe extracranial injuries. Neurol Med Chir (Tokyo). 2018;58(9):393–9.
pubmed: 30101808
doi: 10.2176/nmc.oa.2018-0116
Zygun DA, Kortbeek JB, Fick GH, Laupland KB, Doig CJ. Non-neurologic organ dysfunction in severe traumatic brain injury. Crit Care Med. 2005;33(3):654–60.
pubmed: 15753760
doi: 10.1097/01.CCM.0000155911.01844.54
Robba C, Banzato E, Rebora P, et al. Acute kidney injury in traumatic brain injury patients: results from the collaborative European neurotrauma effectiveness research in traumatic brain injury study. Crit Care Med. 2021;49(1):112–26.
pubmed: 33060506
doi: 10.1097/CCM.0000000000004673
Luu D, Komisarow J, Mills BM, et al. Association of severe acute kidney injury with mortality and healthcare utilization following isolated traumatic brain injury. Neurocrit Care. 2021;35(2):434–40.
pubmed: 33442812
pmcid: 8275693
doi: 10.1007/s12028-020-01183-z
Salim A, Ley EJ, Cryer HG, Margulies DR, Ramicone E, Tillou A. Positive serum ethanol level and mortality in moderate to severe traumatic brain injury. Arch Surg. 2009;144(9):865–71.
pubmed: 19797113
doi: 10.1001/archsurg.2009.158
Shandro JR, Rivara FP, Wang J, Jurkovich GJ, Nathens AB, MacKenzie EJ. Alcohol and risk of mortality in patients with traumatic brain injury. J Trauma. 2009;66(6):1584–90.
pubmed: 19509618
Ditch KL, Flahive JM, West AM, Osgood ML, Muehlschlegel S. Hyperchloremia, not concomitant hypernatremia, independently predicts early mortality in critically ill moderate-severe traumatic brain injury patients. Neurocrit Care. 2020;33(2):533–41.
pubmed: 32043263
doi: 10.1007/s12028-020-00928-0
Maggiore U, Picetti E, Antonucci E, et al. The relation between the incidence of hypernatremia and mortality in patients with severe traumatic brain injury. Crit Care. 2009;13(4):R110.
pubmed: 19583864
pmcid: 2750153
doi: 10.1186/cc7953
Bonow RH, Barber J, Temkin NR, et al. The outcome of severe traumatic brain injury in Latin America. World Neurosurg. 2018;111:e82–90.
pubmed: 29229352
doi: 10.1016/j.wneu.2017.11.171
Czosnyka M, Balestreri M, Steiner L, et al. Age, intracranial pressure, autoregulation, and outcome after brain trauma. J Neurosurg. 2005;102(3):450–4.
pubmed: 15796378
doi: 10.3171/jns.2005.102.3.0450
Kirkness CJ, Burr RL, Mitchell PH, Newell DW. Is there a sex difference in the course following traumatic brain injury? Biol Res Nurs. 2004;5(4):299–310.
pubmed: 15068659
doi: 10.1177/1099800404263050
Bremmer R, de Jong BM, Wagemakers M, Regtien JG, van der Naalt J. The course of intracranial pressure in traumatic brain injury: relation with outcome and CT-characteristics. Neurocrit Care. 2010;12(3):362–8.
pubmed: 20087687
doi: 10.1007/s12028-009-9329-2
Perel P, Arango M, Clayton T, et al. Predicting outcome after traumatic brain injury: practical prognostic models based on large cohort of international patients. BMJ. 2008;336(7641):425–9.
pubmed: 18270239
doi: 10.1136/bmj.39461.643438.25
Majdan M, Lingsma HF, Nieboer D, Mauritz W, Rusnak M, Steyerberg EW. Performance of IMPACT, CRASH and Nijmegen models in predicting six month outcome of patients with severe or moderate TBI: an external validation study. Scand J Trauma Resusc Emerg Med. 2019;22:68.
doi: 10.1186/s13049-014-0068-9
Charry JD, Navarro-Parra S, Solano J, Moscote-Salazar L, PinzÃn MA, Tejada JH. Outcomes of traumatic brain injury: the prognostic accuracy of various scores and models. Neurol Neurochir Pol. 2019;53(1):55–60.
pubmed: 30742300
Han J, King NK, Neilson SJ, Gandhi MP, Ng I. External validation of the CRASH and IMPACT prognostic models in severe traumatic brain injury. J Neurotrauma. 2014;31(13):1146–52.
pubmed: 24568201
doi: 10.1089/neu.2013.3003
Raj R, Siironen J, Skrifvars MB, Hernesniemi J, Kivisaari R. Predicting outcome in traumatic brain injury: development of a novel computerized tomography classification system (Helsinki computerized tomography score). Neurosurgery. 2014;75(6):632–46.
pubmed: 25181434
doi: 10.1227/NEU.0000000000000533
Rostami E, Gustafsson D, Hanell A, et al. Prognosis in moderate-severe traumatic brain injury in a Swedish cohort and external validation of the IMPACT models. Acta Neurochir (Wien). 2021;164(3):615–24.
pubmed: 34936014
doi: 10.1007/s00701-021-05040-6
Zeiler FA, Ercole A, Beqiri E, et al. Association between cerebrovascular reactivity monitoring and mortality is preserved when adjusting for baseline admission characteristics in adult traumatic brain injury: a CENTER-TBI study. J Neurotrauma. 2020;37(10):1233–41.
pubmed: 31760893
pmcid: 7232651
doi: 10.1089/neu.2019.6808
Wan X, Zhao K, Wang S, et al. Is it reliable to predict the outcome of elderly patients with severe traumatic brain injury using the IMPACT prognostic calculator? World Neurosurg. 2019;103:584–90.
doi: 10.1016/j.wneu.2017.04.069
Marshall LF, Marshall SB, Klauber MR, et al. The diagnosis of head injury requires a classification based on computed axial tomography. J Neurotrauma. 1992;9(Suppl 1):287–92.
Thelin EP, Nelson DW, Vehviläinen J, et al. Evaluation of novel computerized tomography scoring systems in human traumatic brain injury: an observational, multicenter study. PLoS Med. 2017;14(8): e1002368.
pubmed: 28771476
pmcid: 5542385
doi: 10.1371/journal.pmed.1002368
Maas AI, Hukkelhoven CW, Marshall LF, Steyerberg EW. Prediction of outcome in traumatic brain injury with computed tomographic characteristics: a comparison between the computed tomographic classification and combinations of computed tomographic predictors. Neurosurgery. 2005;57(6):1173–82.
pubmed: 16331165
doi: 10.1227/01.NEU.0000186013.63046.6B
Maeda Y, Ichikawa R, Misawa J, et al. External validation of the TRISS, CRASH, and IMPACT prognostic models in severe traumatic brain injury in Japan. PLoS ONE. 2019;14(8): e0221791.
pubmed: 31449548
pmcid: 6709937
doi: 10.1371/journal.pone.0221791
Khaki D, Hietanen V, Corell A, Herges HO, Ljungqvist J. Selection of CT variables and prognostic models for outcome prediction in patients with traumatic brain injury. Scand J Trauma Resusc Emerg Med. 2021;29(1):94–00901.
pubmed: 34274009
pmcid: 8285829
doi: 10.1186/s13049-021-00901-6
McCrea MA, Giacino JT, Barber J, et al. Functional outcomes over the first year after moderate to severe traumatic brain injury in the prospective, Longitudinal TRACK-TBI study. JAMA Neurol. 2021;78(8):982–92.
pubmed: 34228047
pmcid: 8261688
doi: 10.1001/jamaneurol.2021.2043
Hutchinson PJ, Kolias AG, Timofeev IS, et al. Trial of decompressive craniectomy for traumatic intracranial hypertension. N Engl J Med. 2016;375(12):1119–30.
pubmed: 27602507
doi: 10.1056/NEJMoa1605215
Elbourn E, Kenny B, Power E, et al. Discourse recovery after severe traumatic brain injury: exploring the first year. Brain Inj. 2019;33(2):143–59.
pubmed: 30465440
doi: 10.1080/02699052.2018.1539246